News & Updates
Filter by Specialty:
Paliperidone 6-month LAI sustains symptomatic, functional remission in schizophrenia at 3 years
Patients with schizophrenia who either continued on the LAI paliperidone palmitate (PP) 6-monthly for up to 3 years or transitioned from PP 3-monthly treatment have sustained symptomatic and functional remission, as shown in a post hoc analysis of the single-arm, OLE study PSY3016
Paliperidone 6-month LAI sustains symptomatic, functional remission in schizophrenia at 3 years
18 Oct 2025
Transcutaneous auricular VNS eases constipation, pain in IBS-C
The use of transcutaneous auricular vagus nerve stimulation (taVNS) is effective in improving constipation and abdominal pain, as well as anxiety and depression, in patients with constipation-predominant irritable bowel syndrome (IBS-C), reports a study.
Transcutaneous auricular VNS eases constipation, pain in IBS-C
07 Oct 2025
Physician-led reviews may prevent overprescription in psychiatric patients
Implementation of physician-led medication reviews through interdisciplinary dialogue can reduce the number of prescribed drugs and potentially inappropriate prescriptions (PIPs) in psychiatric outpatients with coexisting diabetes, a study has shown.
